Pitanium (NASDAQ: PTNM) files 6‑month 2025 interim results and review

Rhea-AI Filing Summary

Pitanium Limited has submitted a Form 6-K as a foreign private issuer to furnish its unaudited interim consolidated financial statements. The report provides financial information as of March 31, 2025 and covers the six-month periods ended March 31, 2025 and 2024.

The filing also includes an accompanying operating and financial review that discusses the Company’s results and condition for these six-month periods. Pitanium highlights that any statements about plans, expectations or strategies are forward-looking and subject to risks such as demand for its products and services, technology changes, competition, pricing, economic conditions and government regulation.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-42669

PITANIUM LIMITED

(Registrant’s Name)

30F, Gravity, 29 Hing Yip Street,

Kwun Tong, Kowloon, Hong Kong

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Information Contained in this Form 6-K Report

Pitanium Limited (“Pitanium”) and its subsidiary (collectively, the “Company”) is furnishing this Form 6-K to provide six-month interim financial statements.

Special Note Regarding Forward-Looking Statements

Statements in this current report with respect to the Company’s current plans, estimates, strategies, beliefs and other statements that are not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include, but are not limited to, those statements using words such as “believe,” “expect,” “plans,” “strategy,” “prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,” “intend,” “seek,” “may,” “might,” “could” or “should,” and words of similar meaning in connection with a discussion of future operations, financial performance, events, or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management’s assumptions, judgments, and beliefs in light of the information currently available to it. The Company cautions investors that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in the forward-looking statements, including but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements. Actual results may differ significantly from those set forth in the forward-looking statements.

All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Financial Statements and Exhibits.

Exhibits:

Exhibit No.		Description
99.1		Unaudited Interim Consolidated Financial Statements as of March 31, 2025 and for the Six Months Ended March 31, 2025 and 2024
99.2		Operating and Financial Review in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended March 31, 2025 and 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: September 15, 2025	Pitanium Limited
	By:	/s/ Ying Yeung Wong
	Name:	Ying Yeung Wong
	Title:	Chief Executive Officer and Director

FAQ

What did Pitanium Limited (PTNM) file in this Form 6-K?

Pitanium Limited filed a Form 6-K to furnish unaudited interim consolidated financial statements as of March 31, 2025 and for the six months ended March 31, 2025 and 2024, along with an operating and financial review.

What periods do Pitanium Limited’s interim financial statements on Form 6-K cover?

The interim financial statements cover March 31, 2025 as the balance sheet date and the six-month periods ended March 31, 2025 and 2024 for results of operations.

What additional analysis accompanies Pitanium Limited’s interim financial statements?

The Form 6-K includes an Operating and Financial Review discussing the unaudited interim consolidated financial statements for the six months ended March 31, 2025 and 2024.

Does Pitanium Limited include forward-looking statements in this Form 6-K?

Yes. Pitanium states that the report contains forward-looking statements about plans, estimates, strategies and expectations, and notes that actual results may differ due to various risks and uncertainties.

What risks does Pitanium Limited highlight in relation to its forward-looking statements?

Pitanium cites risks including product and service demand and acceptance, changes in technology, economic conditions, competition and pricing, government regulation, and other risks discussed in its SEC reports.

Who signed Pitanium Limited’s Form 6-K and in what capacity?

The Form 6-K was signed on behalf of Pitanium Limited by Ying Yeung Wong, who serves as Chief Executive Officer and Director.